KZN Health alert: pink eye cases surge in eThekwini region
THE KwaZulu-Natal Health Department reports a concerning increase in pink eye (conjunctivitis) cases, with 951 cases recorded ...
Mid-Day1 天
Keep an eye on your eyes in this heat, say doctors
With temperatures soaring, Mumbai ophthalmologists and retina specialists say “protect your eyes” as they caution citizens to ...
Ophthalmology Advisor2 天
COVID And The Eye: What We’ve Learned 5 Years Since The Start of The Pandemic
Five years from the start of the COVID-19 pandemic, numerous academic studies have shown how the novel coronavirus affects ocular health.
Allergic Conjunctivitis Market Global Report 2025-2033: Developments in Corticosteroids and ...
The "Allergic Conjunctivitis Market Global Report Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to ResearchAndMarkets.com's offering. The Allergic ...
VietnamPlus5 天
HCM City’s health sector accelerates digital transformation to enhance services
Hospitals in Ho Chi Minh City have digitised patient records, ensuring that information is securely stored while remaining easily retrievable and transferrable across healthcare facilities.
Optometry Advisor6 天
FDA Expands Indication of Dust Mite Allergy Drug to Include Young Children
The US Food and Drug Administration has expanded its indication of Odactra, a house dust mite allergen tablet, for the treatment of house dust mite-induced allergic rhinitis, with or without ...
ALK Abello: ACARIZAX approved in Canada for treatment of young children
ALK (ALKB:DC / OMX: ALK B) today announced that Health Canada has approved ALK's ACARIZAX® tablet for use in children, aged five to 11, with house dust mite (HDM) allergy. ACARIZAX® is now indicated ...
ACARIZAX® approved in Canada for treatment of young children
ALK (ALKB:DC / OMX: ALK B) today announced that Health Canada has approved ALK’s ACARIZAX® tablet for use in children, aged five to 11, with house dust mite (HDM) allergy. ACARIZAX® is now indicated ...